Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.84 USD | -5.43% | -2.07% | -48.77% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
Financials (USD)
Sales 2024 * | 41.22M | Sales 2025 * | 12.17M | Capitalization | 617M |
---|---|---|---|---|---|
Net income 2024 * | -128M | Net income 2025 * | -188M | EV / Sales 2024 * | 9.75 x |
Net cash position 2024 * | 215M | Net cash position 2025 * | 348M | EV / Sales 2025 * | 22.1 x |
P/E ratio 2024 * |
-4.93
x | P/E ratio 2025 * |
-3.61
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.46% |
Latest transcript on EyePoint Pharmaceuticals, Inc.
1 day | -5.43% | ||
1 week | -2.07% | ||
Current month | -32.73% | ||
1 month | -43.46% | ||
3 months | -58.18% | ||
6 months | +78.05% | ||
Current year | -48.77% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
George Elston
DFI | Director of Finance/CFO | 59 | 19-11-13 |
Said Saim
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-06-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
Wendy DiCicco
BRD | Director/Board Member | 56 | 19-07-14 |
David Guyer
BRD | Director/Board Member | 64 | 19-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 11 M€ | -6.03% | - | |
0.37% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 11.84 | -5.43% | 1,042,361 |
24-05-16 | 12.52 | -3.25% | 1,105,149 |
24-05-15 | 12.94 | +3.94% | 978,177 |
24-05-14 | 12.45 | +1.88% | 1,130,790 |
24-05-13 | 12.22 | +1.08% | 1,182,013 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.77% | 617M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- EYPT Stock